This paragraph is not available in English, therefore the Swedish version is shown.
Lena Friberg is since 2014 a Professor in Pharmacometrics. Her research focus is on developing pharmacokinetic and pharmacodynamic models for both desired effects and adverse effects, with a primary focus on anticancer drugs and antibiotics.
Keywords: neutrophils cancer antibiotics antibiotic resistance modelling non-linear mixed effects modelling pharmacokinetics pharmacometrics pharmacodynamics
Also available at
Dr. Friberg is a Professor in Pharmacometrics at the Department of Pharmaceutical Biosciences. She holds a Masters in Pharmaceutical Sciences and obtained a PhD from Uppsala University in 2003 under the supervision of Professor Mats Karlsson. During 2003-2005 she was a postdoc research fellow at the University of Queensland under guidance of Professor Stephen Duffull. She has developed population pharmacokinetic (PK) and pharmacodynamic (PD) models for desired effects and adverse events in a range of therapeutic areas, such as bacterial infections, oncology, schizophrenia, rheumatoid arthritis, and QT-prolongation. Application of PK and PKPD‐models for translation of drug effects from preclinical (in vitro and in vivo) to patients and from early to late clinical development is also a research interest. Lena has published over 90 peer-reviewed research articles and book chapters and is currently the main supervisor of 5 PhD students and is mentoring two postdocs. In addition to teaching undergraduate and master students, she gives courses to professionals on PKPD-modeling. In 2008 she received the Segré Prize from EUFEPS for “distinct research in the Pharmacokinetic-Pharmacodynamic area” and in 2016 the Innovation award from ISoP. Since 2012 she is deputy editor-in-chief of the journal CPT: Pharmacometrics & Systems Pharmacology.
Please contact the directory administrator for the organization (department or similar) to correct possible errors in the information.